Latest Breaking News On - Tyr pharma daily - Page 6 : comparemela.com

aTyr Pharma (NASDAQ:LIFE) Receives New Coverage from Analysts at StockNews com

aTyr Pharma (NASDAQ:LIFE) Receives New Coverage from Analysts at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerRenaissance technologiesRoyal bankSigma securitiesTopco ltdAtyr pharma incTyr pharmaFree reportModerate buyTyr pharma priceGet free reportStreet corpTyr pharma daily

aTyr Pharma (NASDAQ:LIFE) Lifted to Hold at StockNews com

StockNews.com upgraded shares of aTyr Pharma (NASDAQ:LIFE – Free Report) from a sell rating to a hold rating in a research note released on Friday morning. Several other research firms have also commented on LIFE. Piper Sandler lifted their price target on shares of aTyr Pharma from $13.00 to $20.00 and gave the company an […]

United statesPaul schimmelPiper sandlerVirtu financialSquarepoint opsCharles schwab investment management incAtyr pharma incVontobel holding ltdTyr pharmaFree reportModerate buyTyr pharma stock downGet free reportDirector paul schimmelStreet groupSchwab investment management

Piper Sandler Raises aTyr Pharma (NASDAQ:LIFE) Price Target to $20 00

Piper Sandler Raises aTyr Pharma (NASDAQ:LIFE) Price Target to $20 00
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United statesPaul schimmelPiper sandlerJpmorgan chase coSecurities exchange commissionBoothbay fund managementAtyr pharma incTower research capitalMillennium managementRoyal bankTyr pharmaFree reportMarketbeat ratingsModerate buyGet free reportDirector paul schimmel

aTyr Pharma (NASDAQ:LIFE) Price Target Raised to $20 00

aTyr Pharma (NASDAQ:LIFE – Free Report) had its price target boosted by Piper Sandler from $13.00 to $20.00 in a research report released on Thursday, MarketBeat Ratings reports. The firm currently has an overweight rating on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on LIFE. StockNews.com upgraded […]

United statesPaul schimmelPiper sandlerSecurities exchange commissionGeode capital managementSamsara biocapitalJpmorgan chase coSquarepoint opsAtyr pharma incTyr pharma company profileTyr pharmaFree reportMarketbeat ratingsModerate buyGet free reportDirector paul schimmel

aTyr Pharma (NASDAQ:LIFE) Upgraded to Hold by StockNews com

aTyr Pharma (NASDAQ:LIFE) Upgraded to Hold by StockNews com
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United statesPaul schimmelPiper sandlerBoothbay fund managementSecurities exchange commissionAtyr pharma incTower research capitalTyr pharma company profileJpmorgan chase coRoyal bankMillennium managementTyr pharmaFree reportModerate buyGet free reportDirector paul schimmel